Mutations in the metabolic enzymes IDH1 and IDH2 are frequently found in glioma, cholangiocarcinoma, T-cell lymphomas, thyroid cancer, chondrosarcoma, and AML. This evidence concerns the gene IDH2 and cholangiocarcinoma.